CCR5-Delta32 allele is associated with the risk of developing multiple sclerosis in the Iranian population

Cellular and Molecular Neurobiology

Volumn 29, Issue 8, 2009, Pages 1205-1209

  Shahbazi, Majid ^a   Ebadi, Hamid ^b   Fathi, Davood ^b   Roshandel, Danial ^a   Mahamadhoseeni, Mana ^a   Rashidbaghan, Azam ^a   Mahammadi, Narges ^a   Mahammadi, Mahammad Reza ^b   Zamani, Mahdi ^c  

^a GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CCR5 delta32; Genetic susceptibility; Iranian population; Multiple sclerosis (MS); Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR CCR5; DNA;

ADULT; AGAR GEL ELECTROPHORESIS; ALLELE; ARTICLE; BLOOD SAMPLING; CHEMOKINE RECEPTOR CCR5 DELTA32; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE DELETION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IMMUNE SYSTEM; IRAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; POPULATION RESEARCH; PRIORITY JOURNAL; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IRAN; MALE; MULTIPLE SCLEROSIS; RECEPTORS, CCR5;

EID: 77049087335     PISSN: 02724340     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10571-009-9415-1     Document Type: Article

References (30)

1. AF Alshubaili K Alramzy YM Ayyad Y Gerish 2005 Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence Eur Neurol 53 125 131 10.1159/000085556 1:STN:280:DC%2BD2Mzhtlahtg%3D%3D 15860917 (Pubitemid 40864303)
2. KE Balashov JB Rottman HL Weiner WW Hancock 1999 CCR5 (+) and CXCR3 (+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions Proc Natl Acad Sci USA 96 6873 6878 10.1073/pnas.96.12.6873 1:CAS:528:DyaK1MXks1Wktr0%3D 10359806 (Pubitemid 29274977)
3. LF Barcellos AM Schito JB Rimmler E Vittinghoff A Shih R Lincoln, et al. 2000 CC-chemokine receptor 5 polymorphism and age of onset in familial multiple sclerosis. Multiple Sclerosis Genetics Group Immunogenetics 51 281 288 10.1007/s002510050621 1:CAS:528:DC%2BD3cXitFamtrk%3D 10803840
4. BH Bennetts SM Teutsch MM Buhler RN Heard GJ Stewart 1997 The CCR5 deletion mutation fails to protect against multiple sclerosis Hum Immunol 58 52 59 10.1016/S0198-8859(97)00207-3 1:CAS:528:DyaK1cXksFKksQ%3D%3D 9438209 (Pubitemid 28027413)
5. R Bonecchi G Bianchi PP Bordignon D D'Ambrosio R Lang A Borsatti, et al. 1998 Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1 s) and Th2 s J Exp Med 187 129 134 10.1084/jem.187.1.129 1:CAS:528:DyaK1cXjtV2msQ%3D%3D 9419219 (Pubitemid 28044828)
6. PA Calabresi R Martin S Jacobson 1999 Chemokines in chronic progressive neurological diseases: HTLV-1 associated myelopathy and multiple sclerosis J Neurovirol 5 102 108 10.3109/13550289909029751 1:CAS:528:DyaK1MXht1Wmtbk%3D 10190696
7. H Deng R Liu W Ellmeier S Choe D Unutmaz M Burkhart, et al. 1996 Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 661 666 10.1038/381661a0 1:CAS:528:DyaK28XjslClsrk%3D 8649511 (Pubitemid 26197679)
8. DA Duszczyszyn JD Beck J Antel A Bar-Or Y Lapierre V Gadag DG Haegert 2006 Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms Clin Exp Immunol 143 305 313 10.1111/j.1365-2249.2005.02990.x 1:CAS:528:DC%2BD28Xit1amu7c%3D 16412055
9. OO Favorova TV Andreewski AN Boiko MA Sudomoina AD Alekseenkov OG Kulakova, et al. 2002 The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians Neurology 59 1652 1655 1:CAS:528:DC%2BD38XosVCmtr0%3D 12451219
10. C Gerard BJ Rollins 2001 Chemokines and disease Nat Immunol 2 108 115 10.1038/84209 1:CAS:528:DC%2BD3MXhtVOlsL4%3D 11175802 (Pubitemid 33707927)
11. N Grytten SB Glad JH Aarseth H Nyland R Midgard KM Myhr 2006 A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway Neurology 66 182 186 10.1212/01.wnl.0000195549.95448.b9 1:STN:280: DC%2BD28%2Fks1emuw%3D%3D 16434650 (Pubitemid 43970150)
12. T Hansen A Skytthe E Stenager HC Petersen H Brønnum-Hansen KO Kyvik 2005 Concordance for multiple sclerosis in Danish twins: an update of a nationwide study Mult Scler 11 504 510 10.1191/1352458505ms1220oa 1:STN:280:DC%2BD2MritVKmtg%3D%3D 16193885 (Pubitemid 41387692)
13. OH Kantarci Y Morales PA Ziemer DD Hebrink DJ Mahad EJ Atkinson, et al. 2005 CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis J Neuroimmunol 169 137 143 10.1016/j.jneuroim.2005.07.025 1:CAS:528:DC%2BD2MXhtFKhsrnO 16182378 (Pubitemid 41527099)
14. R Kantor M Bakhanashvili A Achiron 2003 A mutated CCR5 gene may have favorable prognostic implications in MS Neurology 61 238 240 1:CAS:528:DC%2BD3sXltVGqsbY%3D 12874407
15. WJ Karpus RM Ransohoff 1998 Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis J Immunol 161 2667 2671 1:CAS:528:DyaK1cXmtVGntbg%3D 9743321
16. R Liu WA Paxton S Choe D Ceradini SR Martin R Horuk, et al. 1996 Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection Cell 86 367 377 10.1016/S0092-8674(00)80110-5 1:CAS:528:DyaK28XltVSks7k%3D 8756719 (Pubitemid 26272077)
17. WI McDonald A Compston G Edan D Goodkin HP Hartung FD Lublin, et al. 2001 Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis Ann Neurol 50 121 127 10.1002/ana.1032 1:STN:280:DC%2BD38%2FitFOhug%3D%3D 11456302 (Pubitemid 32591472)
18. D Otaegui J Ruíz-Martínez J Olaskoaga JI Emparanza AL de Munain 2007 Influence of CCR5-Delta32 genotype in Spanish population with multiple sclerosis Neurogenetics 8 201 205 10.1007/s10048-007-0085-1 1:STN:280:DC%2BD2svgtFSisA%3D%3D 17351762 (Pubitemid 47051009)
19. K Pulkkinen M Luomala H Kuusisto T Lehtimäki M Saarela TO Jalonen I Elovaara 2004 Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis Acta Neurol Scand 109 342 347 10.1046/j.1600-0404.2003.00233.x 1:CAS:528:DC%2BD2cXktlOisrg%3D 15080861 (Pubitemid 38580902)
20. S Ristić L Lovrecić N Starcević-Cizmarević B Brajenović-Milić SS Jazbec V Barac-Latas, et al. 2006 No association of CCR5delta32 gene mutation with multiple sclerosis in Croatian and Slovenian patients Mult Scler 12 360 362 10.1191/135248506ms1305sr 16764352 (Pubitemid 43827194)
21. JB Rottman KP Ganley K Williams L Wu CR Mackay DJ Ringler 1997 Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection Am J Pathol 151 1341 1351 1:CAS:528:DyaK2sXntlOktr4%3D 9358760
22. M Samson F Libert BJ Doranz J Rucker C Liesnard CM Farber, et al. 1996 Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene Nature 382 722 725 10.1038/382722a0 1:CAS:528:DyaK28Xlt1ylt7s%3D 8751444 (Pubitemid 26282179)
23. F Sellebjerg HO Madsen CV Jensen J Jensen P Garred 2000 CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis J Neuroimmunol 102 98 106 10.1016/S0165-5728(99)00166-6 1:CAS:528: DyaK1MXotVKqt7w%3D 10626673
24. M Shahbazi V Pravica N Nasreen H Fakhoury AA Fryer RC Strange, et al. 2002 Association between functional polymorphism in EGF gene and malignant melanoma Lancet 359 397 401 10.1016/S0140-6736(02)07600-6 1:CAS:528: DC%2BD38XhtFyrs7g%3D 11844511 (Pubitemid 34158948)
25. JA Silversides SV Heggarty GV McDonnell SA Hawkins CA Graham 2004 Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course Mult Scler 10 149 152 10.1191/1352458504ms994oa 1:CAS:528:DC%2BD2cXktlKgt7w%3D 15124759 (Pubitemid 38499906)
26. J Simpson P Rezaie J Newcombe ML Cuzner D Male MN Woodroofe 2000 Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue J Neuroimmunol 108 192 200 10.1016/S0165-5728(00)00274-5 1:CAS:528:DC%2BD3cXkvFSgsL4%3D 10900353 (Pubitemid 30438767)
27. TL Sørensen M Tani J Jensen V Pierce C Lucchinetti VA Folcik, et al. 1999 Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients J Clin Invest 103 807 815 10.1172/JCI5150 10079101
28. T Strunk S Bubel B Mascher P Schlenke H Kirchner KP Wandinger 2000 Increased numbers of CCR5+ interferon-gamma- and tumor necrosis factor-alpha-secreting T lymphocytes in multiple sclerosis patients Ann Neurol 47 269 273 10.1002/1531-8249(200002)47:2<269::AID-ANA23>3.0.CO;2-G 1:CAS:528:DC%2BD3cXhtV2mt70%3D 10665504 (Pubitemid 30078580)
29. V Viglietta C Baecher-Allan HL Weiner DA Hafler 2004 Loss of functional suppression by CD4+ CD25+ regulatory T cells in patients with multiple sclerosis J Exp Med 199 971 979 10.1084/jem.20031579 1:CAS:528:DC%2BD2cXjtVejurw%3D 15067033 (Pubitemid 38481088)
30. CJ Willer DA Dyment NJ Risch AD Sadovnick GC Ebers Canadian Collaborative Study Group 2003 Twin concordance and sibling recurrence rates in multiple sclerosis Proc Natl Acad Sci USA 100 12877 12882 10.1073/pnas.1932604100 1:CAS:528:DC%2BD3sXoslKnurc%3D 14569025 (Pubitemid 37339993)